Investment Trusts

International Biotechnology Trust

IBT:LSE

International Biotechnology Trust

  • Price (GBX)642.00
  • Today's Change10.00 / 1.58%
  • Shares traded26.92k
  • 1 Year change-2.43%
  • Beta0.1752
Data delayed at least 20 minutes, as of May 03 2024 16:05 BST.
More ▼

Top holdings

34.31%Per cent of portfolio in top holdings
Holding% of portfolio
Amgen Inc5.65%
Cytokinetics Inc5.07%
Gilead Sciences Inc4.39%
Vera Therapeutics Inc Class A4.32%
Biomarin Pharmaceutical Inc4.31%
Incyte Corp3.66%
Supernus Pharmaceuticals Inc3.47%
Alnylam Pharmaceuticals Inc3.44%

Sector weighting

Sector% of portfolio
Healthcare100.87%
Consumer Defensive0.40%

Regional holdings

Holding% of portfolio
USA85.43%
China3.95%
UK2.84%
Netherlands2.63%
Denmark2.07%
Germany1.77%
Canada1.12%
Other1.48%
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.